ATE334672T1 - Ginkolide zur hemmung der membranexpression - Google Patents

Ginkolide zur hemmung der membranexpression

Info

Publication number
ATE334672T1
ATE334672T1 AT96938209T AT96938209T ATE334672T1 AT E334672 T1 ATE334672 T1 AT E334672T1 AT 96938209 T AT96938209 T AT 96938209T AT 96938209 T AT96938209 T AT 96938209T AT E334672 T1 ATE334672 T1 AT E334672T1
Authority
AT
Austria
Prior art keywords
ginkolide
membrane expression
inhibiting membrane
inhibiting
expression
Prior art date
Application number
AT96938209T
Other languages
English (en)
Inventor
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE334672T1 publication Critical patent/ATE334672T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT96938209T 1995-11-09 1996-11-08 Ginkolide zur hemmung der membranexpression ATE334672T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US733795P 1995-11-09 1995-11-09
US57590295A 1995-12-20 1995-12-20

Publications (1)

Publication Number Publication Date
ATE334672T1 true ATE334672T1 (de) 2006-08-15

Family

ID=26676857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96938209T ATE334672T1 (de) 1995-11-09 1996-11-08 Ginkolide zur hemmung der membranexpression

Country Status (12)

Country Link
EP (1) EP0862428B1 (de)
JP (1) JP2000505057A (de)
AT (1) ATE334672T1 (de)
AU (1) AU724416B2 (de)
CA (1) CA2235416A1 (de)
CZ (1) CZ140598A3 (de)
DE (1) DE69636412T2 (de)
ES (1) ES2264802T3 (de)
HU (1) HUP9903723A3 (de)
MX (1) MX9803681A (de)
NZ (1) NZ322050A (de)
WO (1) WO1997017068A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE401094T1 (de) * 1999-08-12 2008-08-15 Sod Conseils Rech Applic Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist
EP1865319A1 (de) 1999-08-12 2007-12-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Methode zur Bestimmung ob ein Tumor empfindlich ist gegenüber Behandlung mit Ginkgo Biloba Extrakt oder Ginkgolide B, wobei festgestellt wird ob der Tumor durch Überexpression des peripheren Benzodiazepin Rezeptor Proteins characterisiert ist

Also Published As

Publication number Publication date
NZ322050A (en) 2000-07-28
ES2264802T3 (es) 2007-01-16
CZ140598A3 (cs) 1998-10-14
MX9803681A (es) 1998-11-29
HUP9903723A2 (hu) 2000-03-28
JP2000505057A (ja) 2000-04-25
WO1997017068A1 (en) 1997-05-15
CA2235416A1 (en) 1997-05-15
AU724416B2 (en) 2000-09-21
DE69636412D1 (de) 2006-09-14
AU7571796A (en) 1997-05-29
DE69636412T2 (de) 2007-03-15
HUP9903723A3 (en) 2000-05-29
EP0862428A1 (de) 1998-09-09
EP0862428B1 (de) 2006-08-02

Similar Documents

Publication Publication Date Title
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
FI971536A0 (fi) Keratinosyytti-kasvutekijän analogeja
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
PL317705A1 (en) Pyrazole and pyrrole pyridines
MY119711A (en) Method of inhibiting photoaging of skin
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
MY120511A (en) New pesticides
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69636412D1 (de) Ginkolide zur hemmung der membranexpression
PT874839E (pt) Derivados de furano- e tiofeno-carbotioamidas sua preparacao e sua utilizacao como inibidores da replicacao do hiv-1 e de mutantes do hiv-1
BR9606955A (pt) Heterocicloalquenos substituísos
ZA9610073B (en) Method of using beta-interferons to treat restenosis
ATE222498T1 (de) Putamen ovi
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
NO981020L (no) Transdermalt terapautisk system for silatranforbindelser
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
TR199801800T2 (xx) Uykusuzluk tedavisi.
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
UA32586C2 (uk) Спосіб фізичної підготовки спортсмена "дракон"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties